Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients

Abstract Background With a series of clinical trials confirming the sensitivity of small cell lung cancer (SCLC) to immunotherapy, research on personalized treatment for SCLC has gained increasing attention. Currently, the most widely accepted subtype of SCLC is based on the expression levels of Ach...

詳細記述

書誌詳細

出版年:	BMC Pulmonary Medicine
主要な著者:	Jianan Li, Wentao Zhang, Yi Zhao, Jixian Li, Yuanliu Nie, Alei Feng, Qiang Li, Fengge Zhou, Renya Zeng, Zhe Yang
フォーマット:	論文
言語:	英語
出版事項:	BMC 2024-08-01
主題:	Small cell lung carcinoma Extensive-stage Prognosis Molecular subtype Immunotherapy
オンライン･アクセス:	https://doi.org/10.1186/s12890-024-03221-4